液体过负荷与接受连续性肾脏替代治疗的急性肾损伤重症患者主要不良肾脏事件相关
该回顾性队列研究纳入481例因急性肾损伤需连续性肾脏替代治疗的重症成人,评估入ICU至启动连续性肾脏替代治疗期间的液体平衡(按体重校正)。主要终点为出院后90天内死亡、依赖肾脏替代治疗或不能恢复至基线估算肾小球滤过率50%的复合终点。液体过负荷>10%者主要不良肾脏事件发生率79.4%,≤10%者为71.6%(p=0.047);多因素回归显示液体过负荷>10%与主要不良肾脏事件风险升高58%相关(p=0.046),且独立于连续性肾脏替代治疗启动时机。液体过负荷>10%还与医院死亡率升高82%(p=0.004)及无呼吸机天数减少2.5天(p=0.044)独立相关。
要点
- 液体过负荷>10%者90天主要不良肾脏事件发生率79.4%,≤10%者为71.6%(p=0.047)。
- 多因素回归显示液体过负荷>10%与主要不良肾脏事件风险升高58%相关(p=0.046),独立于连续性肾脏替代治疗启动时机。
- 液体过负荷>10%与医院死亡率升高82%(p=0.004)独立相关。
- 液体过负荷>10%与无呼吸机天数减少2.5天相关(p=0.044)。
- 入ICU至启动连续性肾脏替代治疗每延迟1天,主要不良肾脏事件风险升高2.7%(p=0.024)。
适用人群与场景
- 因急性肾损伤需连续性肾脏替代治疗的重症成人(481例),收治于三级医疗中心ICU。
诊断标准与关键阈值
- 液体过负荷:入ICU至启动连续性肾脏替代治疗期间的液体平衡,按体重校正,以>10%为界值。
- 主要不良肾脏事件:出院后90天内死亡、依赖肾脏替代治疗或(未接受肾脏替代治疗者)不能恢复至基线估算肾小球滤过率50%的复合终点。
研究设计与关键结果
- 回顾性队列研究,纳入481例因急性肾损伤需连续性肾脏替代治疗的重症成人。
- 液体过负荷>10%者主要不良肾脏事件发生率79.4%,≤10%者为71.6%(p=0.047)。
- 多因素logistic回归显示液体过负荷>10%与主要不良肾脏事件风险升高58%相关(p=0.046),校正连续性肾脏替代治疗启动时机后仍显著。
- 入ICU至启动连续性肾脏替代治疗每延迟1天,主要不良肾脏事件风险升高2.7%(p=0.024)。
- 液体过负荷>10%与医院死亡率升高82%独立相关(p=0.004)。
- 液体过负荷>10%与无呼吸机天数减少2.5天相关(p=0.044)。
证据类型、等级与局限
- 证据类型:回顾性队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为液体过负荷是可干预的危险因素,独立于连续性肾脏替代治疗启动时机,应在干预性研究中进一步检验。
- 该研究提示需关注急性肾损伤需连续性肾脏替代治疗患者的液体过负荷(>10%)及启动连续性肾脏替代治疗的时机,但原文未据此给出具体推荐。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: We examined the association between fluid overload and major adverse kidney events in critically ill patients requiring continuous renal replacement therapy for acute kidney injury.
DESIGN: Retrospective cohort study.
SETTING: ICU in a tertiary medical center.
PATIENTS: Four-hundred eighty-one critically ill adults requiring continuous renal replacement therapy for acute kidney injury.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Fluid overload was assessed as fluid balance from admission to continuous renal replacement therapy initiation, adjusted for body weight. Major adverse kidney events were defined as a composite of mortality, renal replacement therapy-dependence or inability to recover 50% of baseline estimated glomerular filtration rate (if not on renal replacement therapy) evaluated up to 90 days after discharge. Patients with fluid overload less than or equal to 10% were less likely to experience major adverse kidney events than those with fluid overload greater than 10% (71.6% vs 79.4%; p = 0.047). Multivariable logistic regression showed that fluid overload greater than 10% was associated with a 58% increased odds of major adverse kidney events (p = 0.046), even after adjusting for timing of continuous renal replacement therapy initiation. There was also a 2.7% increased odds of major adverse kidney events for every 1 day increase from ICU admission to continuous renal replacement therapy initiation (p = 0.024). Fluid overload greater than 10% was also found to be independently associated with an 82% increased odds of hospital mortality (p = 0.004) and 2.5 fewer ventilator-free days (p = 0.044), compared with fluid overload less than or equal to 10%.
CONCLUSIONS: In critically ill patients with acute kidney injury requiring continuous renal replacement therapy, greater than 10% fluid overload was associated with higher risk of 90-day major adverse kidney events, including mortality and decreased renal recovery. Increased time between ICU admission and continuous renal replacement therapy initiation was also associated with decreased renal recovery. Fluid overload represents a potentially modifiable risk factor, independent of timing of continuous renal replacement therapy initiation, that should be further examined in interventional studies.
参考来源
- Woodward CW, Lambert J, Ortiz-Soriano V, et al. Fluid Overload Associates With Major Adverse Kidney Events in Critically Ill Patients With Acute Kidney Injury Requiring Continuous Renal Replacement Therapy. Crit Care Med. 2019. PMID: 31162196. doi:10.1097/CCM.0000000000003862
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。